2010
DOI: 10.1007/s11248-010-9461-y
|View full text |Cite
|
Sign up to set email alerts
|

Accumulation of functional recombinant human coagulation factor IX in transgenic soybean seeds

Abstract: The seed-based production of recombinant proteins is an efficient strategy to achieve the accumulation, correct folding, and increased stability of these recombinant proteins. Among potential plant molecular farming systems, soybean [Glycine max (L.) Merrill] is a viable option for the production of recombinant proteins due to its high protein content, known regulatory sequences, efficient gene transfer protocols, and a scalable production system under greenhouse conditions. We report here the expression and s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
41
0
2

Year Published

2011
2011
2021
2021

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 43 publications
(45 citation statements)
references
References 80 publications
0
41
0
2
Order By: Relevance
“…The percentages of each detected protein are listed in Table 2. CTAG had an expression value of 0.1%, which is low compared with that of the other transgenic soybean seeds that express hGH [9] (2.9%), but it had a similar value compared with factor IX expression (0.2%) [10]. Other soybean proteins, such as b-conglycinin and glycinin, have been shown to exhibit the expected values that would be predicted for these storage proteins in soybean seeds [53].…”
Section: Expression Analysismentioning
confidence: 82%
See 1 more Smart Citation
“…The percentages of each detected protein are listed in Table 2. CTAG had an expression value of 0.1%, which is low compared with that of the other transgenic soybean seeds that express hGH [9] (2.9%), but it had a similar value compared with factor IX expression (0.2%) [10]. Other soybean proteins, such as b-conglycinin and glycinin, have been shown to exhibit the expected values that would be predicted for these storage proteins in soybean seeds [53].…”
Section: Expression Analysismentioning
confidence: 82%
“…Seeds are an advantageous production platform for recombinant proteins for several reasons: they can undergo long-term storage at ambient temperatures [5,6], they can provide an appropriate biochemical environment for protein stability through the creation of specialized storage compartments [6,7], they are not contaminated by human or animal pathogens [8], their desiccation characteristics prevent them from undergoing non-enzymatic hydrolysis or protease degradation [5,8], and they do not carry the harmful substances that are present in some plant leaves, which is important for downstream processing [3,8]. We recently produced several transgenic soybean plants that express important pharmaceutical molecules, such as proinsulin [6], human growth hormone (hGH) [9] and human coagulation factor IX (hFIX) [10], which demonstrate the versatility of this system. However, the production of these transgenic lines is extremely time consuming [11] and requires at least 150 days to obtain the first seeds and another three years to generate a homozygous line.…”
Section: Introductionmentioning
confidence: 99%
“…While this treatment is effective at preventing and arresting hemorrhage, it is very costly and the protein is difficult to produce in large quantities. Using a biolistic transformation approach, hFIX expression was targeted to soybean seeds using the soy 7S promoter and coixin signal peptide [75]. Recombinant hFIX protein accumulated to 0.23% of seed TSP, and purified protein exhibited blood-clotting activity up to 1.…”
Section: Therapeuticsmentioning
confidence: 99%
“…Expression of inactive FIX in transgenic plants has been reported to date in transgenic tomatoes [61] and soybean seeds [62]. The expression level of FIX in tomatoes was quite low: 15.84 µg/kg of fresh fruits.…”
Section: Transgenic Organismsmentioning
confidence: 99%